124 related articles for article (PubMed ID: 12225729)
21. Preconditioning of the ischaemic myocardium; involvement of the L-arginine nitric oxide pathway.
Vegh A; Szekeres L; Parratt J
Br J Pharmacol; 1992 Nov; 107(3):648-52. PubMed ID: 1472963
[TBL] [Abstract][Full Text] [Related]
22. Attenuation of myocardial ischemia/reperfusion injury in mice with myocyte-specific overexpression of endothelial nitric oxide synthase.
Brunner F; Maier R; Andrew P; Wölkart G; Zechner R; Mayer B
Cardiovasc Res; 2003 Jan; 57(1):55-62. PubMed ID: 12504814
[TBL] [Abstract][Full Text] [Related]
23. Differential effects of selective and non-selective nitric oxide synthase inhibitors on the blood perfusion of ischemia-reperfused myocardium in dogs.
Luo Y; Cha DG; Liu YL; Zhou SF
Med Sci Monit Basic Res; 2013 Jun; 19():181-6. PubMed ID: 23807023
[TBL] [Abstract][Full Text] [Related]
24. Cardioprotective effects of long-term treatment with raloxifene, a selective estrogen receptor modulator, on myocardial ischemia/reperfusion injury in ovariectomized rats.
Chung MT; Cheng PY; Lam KK; Chen SY; Ting YF; Yen MH; Lee YM
Menopause; 2010; 17(1):127-34. PubMed ID: 19745773
[TBL] [Abstract][Full Text] [Related]
25. Characterisation of the relaxant response to raloxifene in porcine coronary arteries.
Moritz A; Radtke OA; Gust R; Glusa E; Pertz HH
Eur J Pharmacol; 2006 Sep; 545(2-3):153-60. PubMed ID: 16859668
[TBL] [Abstract][Full Text] [Related]
26. Raloxifene acutely relaxes rabbit coronary arteries in vitro by an estrogen receptor-dependent and nitric oxide-dependent mechanism.
Figtree GA; Lu Y; Webb CM; Collins P
Circulation; 1999 Sep; 100(10):1095-101. PubMed ID: 10477535
[TBL] [Abstract][Full Text] [Related]
27. Reduction of myocardial infarct size by fluvastatin.
Tiefenbacher CP; Kapitza J; Dietz V; Lee CH; Niroomand F
Am J Physiol Heart Circ Physiol; 2003 Jul; 285(1):H59-64. PubMed ID: 12623790
[TBL] [Abstract][Full Text] [Related]
28. The role of NO in ischemia/reperfusion injury in isolated rat heart.
Andelová E; Barteková M; Pancza D; Styk J; Ravingerová T
Gen Physiol Biophys; 2005 Dec; 24(4):411-26. PubMed ID: 16474186
[TBL] [Abstract][Full Text] [Related]
29. Protection from renal ischemia reperfusion injury by an endothelin-A receptor antagonist BQ-123 in relation to nitric oxide production.
Erdogan H; Fadillioglu E; Emre MH
Toxicology; 2006 Dec; 228(2-3):219-28. PubMed ID: 17046139
[TBL] [Abstract][Full Text] [Related]
30. Antineutrophil and myocardial protecting actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion of dogs.
Lefer DJ; Nakanishi K; Johnston WE; Vinten-Johansen J
Circulation; 1993 Nov; 88(5 Pt 1):2337-50. PubMed ID: 8222127
[TBL] [Abstract][Full Text] [Related]
31. [Cardioprotective effects of sodium ferulate mediated by nitric oxide on ischemia-reperfusion injured myocardium: experiment with isolated rat hearts].
Liu JC; Kang J; Shao LJ; He M
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):987-91. PubMed ID: 16759542
[TBL] [Abstract][Full Text] [Related]
32. Cilostazol protects the heart against ischaemia reperfusion injury in a rabbit model of myocardial infarction: focus on adenosine, nitric oxide and mitochondrial ATP-sensitive potassium channels.
Bai Y; Muqier ; Murakami H; Iwasa M; Sumi S; Yamada Y; Ushikoshi H; Aoyama T; Nishigaki K; Takemura G; Uno B; Minatoguchi S
Clin Exp Pharmacol Physiol; 2011 Oct; 38(10):658-65. PubMed ID: 21679220
[TBL] [Abstract][Full Text] [Related]
33. Nitric oxide synthase inhibitors decrease coronary sinus-free radical concentration and ameliorate myocardial stunning in an ischemia-reperfusion model.
Zhang Y; Bissing JW; Xu L; Ryan AJ; Martin SM; Miller FJ; Kregel KC; Buettner GR; Kerber RE
J Am Coll Cardiol; 2001 Aug; 38(2):546-54. PubMed ID: 11499751
[TBL] [Abstract][Full Text] [Related]
34. Effect of L-arginine on metabolic recovery of the ischemic myocardium.
Carrier M; Khalil A; Tourigny A; Solymoss BC; Pelletier LC
Ann Thorac Surg; 1996 Jun; 61(6):1651-7. PubMed ID: 8651764
[TBL] [Abstract][Full Text] [Related]
35. Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs.
Yao Z; Gross GJ
Circulation; 1994 Apr; 89(4):1769-75. PubMed ID: 8149542
[TBL] [Abstract][Full Text] [Related]
36. The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
Hartman JC
Ann Thorac Surg; 1995 Sep; 60(3):789-92. PubMed ID: 7545893
[TBL] [Abstract][Full Text] [Related]
37. [Correlation of limb and myocardial ischemia postconditioning with acute myocardial reperfusion injury].
Zhang XH; Li CM; Ma XJ; Luo M
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(12):841-5. PubMed ID: 16681977
[TBL] [Abstract][Full Text] [Related]
38. The dual effects of nitric oxide synthase inhibitors on ischemia-reperfusion injury in rat hearts.
Kobara M; Tatsumi T; Takeda M; Mano A; Yamanaka S; Shiraishi J; Keira N; Matoba S; Asayama J; Nakagawa M
Basic Res Cardiol; 2003 Sep; 98(5):319-28. PubMed ID: 12955405
[TBL] [Abstract][Full Text] [Related]
39. Endogenous protection against reperfusion-induced ventricular fibrillation: role of neuronal versus non-neuronal sources of nitric oxide and species dependence in the rat versus rabbit isolated heart.
Pabla R; Curtis MJ
J Mol Cell Cardiol; 1996 Oct; 28(10):2097-110. PubMed ID: 8930805
[TBL] [Abstract][Full Text] [Related]
40. The role of nitric oxide, K(+)(ATP) channels, and cGMP in the preconditioning response of the rabbit.
Horimoto H; Gaudette GR; Saltman AE; Krukenkamp IB
J Surg Res; 2000 Jul; 92(1):56-63. PubMed ID: 10864483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
